These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 8471002
21. The influence of heart rate on ouabain cardiotoxicity in cats with spinal cord transection. Cagin NA, Somberg J, Freeman E, Bounous H, Raines A, Levitt B. Eur J Pharmacol; 1978 Jul 01; 50(1):69-74. PubMed ID: 28234 [Abstract] [Full Text] [Related]
24. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations. Haustein KO, Graumann G, Stephan B. Acta Biol Med Ger; 1975 Jul 01; 34(6):1065-73. PubMed ID: 1199622 [Abstract] [Full Text] [Related]
25. Ouabain cardiotoxicity, a reassessment of methodology. Cagin NA, Somberg JC, Bounous H, Mittag T, Raines A, Levitt B. Arch Int Pharmacodyn Ther; 1976 Dec 01; 224(2):230-8. PubMed ID: 1015920 [Abstract] [Full Text] [Related]
26. Effects of verapamil on positive inotropic stimulation in the left atrium and ventricle of conscious dogs. Goldman S, Olajos M, Morkin E. J Pharmacol Exp Ther; 1982 Jul 01; 222(1):270-5. PubMed ID: 7086704 [Abstract] [Full Text] [Related]
29. Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. II. Studies with dopamine and ouabain in the barbiturate-anesthetized dog. Rude RE, Izquierdo C, Bush LR, Buja LM, Willerson JT. J Cardiovasc Pharmacol; 1983 Jul 01; 5(5):717-24. PubMed ID: 6195456 [Abstract] [Full Text] [Related]
33. Pharmacological investigation on asclepin--a new cardenolide from Asclepias curassavica. Part II. Comparative studies on the inotropic and toxic effects of asclepin, g-strophantin, digoxin and digitoxin). Patnaik GK, Köhler E. Arzneimittelforschung; 1978 Jul 01; 28(8):1368-72. PubMed ID: 380581 [Abstract] [Full Text] [Related]
34. Interaction of DPI 201-106 with cardiac glycosides. Scholtysik G, Salzmann R, Gerber W. J Cardiovasc Pharmacol; 1989 Feb 01; 13(2):342-7. PubMed ID: 2468968 [Abstract] [Full Text] [Related]
35. Protective effect of verapamil upon ouabain-induced cardiac arrhythmias. Khatter JC, Navaratnam S, Hoeschen RJ. Pharmacology; 1988 Feb 01; 36(6):380-9. PubMed ID: 3420160 [Abstract] [Full Text] [Related]
36. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent. Greenberg S, Touhey B. J Cardiovasc Pharmacol; 1991 Jan 01; 17(1):145-53. PubMed ID: 1708048 [Abstract] [Full Text] [Related]
37. Influence of nicorandil, an antianginal agent, on the therapeutic and toxic cardiovascular actions of ouabain in the anaesthetized dog. Nakamura Y, Akima M, Sakai K. Clin Exp Pharmacol Physiol; 1984 Jan 01; 11(3):275-83. PubMed ID: 6235076 [Abstract] [Full Text] [Related]
38. The role of arterial baroreceptors in mediating the cardiovascular response to a cardiac glycoside in conscious dogs. McRitchie RJ, Vatner SF. Circ Res; 1976 Apr 01; 38(4):321-6. PubMed ID: 1260975 [Abstract] [Full Text] [Related]
39. Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action. Hayes JS, Pollock GD, Wilson H, Bowling N, Robertson DW. J Cardiovasc Pharmacol; 1987 Apr 01; 9(4):425-34. PubMed ID: 2438505 [Abstract] [Full Text] [Related]
40. Ouabain effects on intracellular potassium activity and contractile force in cat papillary muscle. Browning DJ, Guarnieri T, Strauss HC. J Clin Invest; 1981 Oct 01; 68(4):942-56. PubMed ID: 7287907 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]